Abstract
Bimodal fluorescence and magnetic resonance imaging (FLI/MRI) is important for early diagnosis of malignant tumors. Yet, facile and opportune strategies to synergistically enhance fluorescence intensity and magnetic resonance (MR) contrast effect have been rarely reported. Here, a facile albumin cage (AC) strategy is provided to synergistically enhance the fluorescence intensity by aggregation-induced emission (AIE) and MR contrast with prolonged rotational correlation time (τR) of Gd(III) chelates and diffusion correlation time (τD) of surrounding water molecules. The amphiphilic bimodal FLI/MRI probe of NGd, could be facilely loaded into ACs to generate supramolecular structure of NGd-albumin cages (NGd-ACs), which show excellent biocompatibility and biosafety, and exhibit superior fluorescence quantum yield and r1 over NGd with 6- and 8-fold enhancement, respectively. Moreover, compared with clinical MRI contrast agent of Gd-DOTA, r1 of NGd-AC shows 17-fold enhancement. As a result, NGd-ACs successfully elicit high-performance bimodal FLI/MRI in vitro and brighter MR signals are observed in liver and tumor after intravenous injection of NGd-ACs with a dosage of 6 μmol Gd(III)/kg body weight. This strategy is generic and feasible, and successfully realizes a “1+1>2” effect for dual-modal FLI/MRI.



![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://www.cambridge.org/engage/assets/public/coe/logo/orcid.png)